Heart rate-lowering therapy in gout patients with stable coronary artery disease: focus on ivabradine

by N. N. Kushnarenko, T. A. Medvedeva, M. Yu. Mishko, T. M. Karavaeva
Published 2020-08-01

HE ROLE OF FATTY ACID CONTENTS OF ERYTHROCYTES MEMBRANES IN CARDIOHEMODYNAMICS DISORDER IN GOUT PATIENTS WITH INSULIN RESISTANCE SYNDROME

by N. N. Kushnarenko, T. A. Medvedeva, A. V. Govorin, M. Yu. Mishko
Published 2018-06-01

Renal filtration function in patients with gout

by N. N. Kushnarenko, T. A. Medvedeva, A. V. Govorin, M. Yu. Mishko
Published 2016-09-01

Clinical and pathogenetic significance of angiogenesis factors (VEGF-A, HGF, IGF-1) in the development of cardiometabolic disorders in gout patients having different obesity phenot...

by T. A. Medvedeva, N. N. Kushnarenko, M. Yu. Mishko, T. M. Karavaeva, E. V. Volgina
Published 2021-04-01